Neuropace
NPCE
90 hedge funds and large institutions have $294M invested in Neuropace in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 6 closing their positions.
467% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 6
340% more call options, than puts
Call options by funds: $22K | Put options by funds: $5K
107% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 14
45% more funds holding
Funds holding: 62 → 90 (+28)
26% more capital invested
Capital invested by funds: $234M → $294M (+$60.6M)
3.59% more ownership
Funds ownership: 69.91% → 73.5% (+3.6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$37.2M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$19.8M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$10.1M |
| 4 |
AC
Armistice Capital
New York
|
+$7.02M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KL
KCK Ltd
Hamilton,
Bermuda
|
-$59M |
| 2 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
-$6.67M |
| 3 |
Millennium Management
New York
|
-$4.69M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$3.13M |
| 5 |
Jane Street
New York
|
-$1.12M |
NPCE Hedge Fund Activity: Q1 2025 in Review
90 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q1 2025, worth a combined $294M — up 26% from $234M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new NPCE positions and 6 closed out — a net gain of 28 holders — while 29 added to existing stakes and 14 trimmed.
The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $37.2M. The largest seller was KCK Ltd, exiting entirely with an estimated $59M sold.
- 90 institutional investors held Neuropace (NPCE) as of Q1 2025, up from 62 in Q4 2024.
- Funds reported $294M of Neuropace stock for Q1 2025, up 26% quarter-over-quarter.
- 34 funds opened new Neuropace positions in Q1 2025 and 6 closed out, a net change of +28 holders.
- The largest Neuropace buyer in Q1 2025 was Polar Capital Holdings, an estimated $37.2M added.
- The largest Neuropace seller in Q1 2025 was KCK Ltd, an estimated $59M sold.
Based on aggregated 13F filings for Q1 2025.